Alpha-3 beta-2 nicotinic acetylcholine receptor (α3β2 nAChR) (α3β2 nAChR)

The Alpha-3 beta-2 nicotinic acetylcholine receptor (α3β2 nAChR) is a heteropentameric ligand-gated ion channel composed of α3 and β2 subunits [1, 2]. While the α3 subunit is predominantly expressed in the peripheral nervous system within autonomic ganglia, where it typically pairs with the β4 subunit, the α3β2 subtype is a significant component of the central nervous system, particularly in hippocampal interneurons [2, 4]. In the hippocampus, these receptors are involved in regulating the synchronous firing of pyramidal cells and modulating the release of various neurotransmitters [2]. The receptor can exist in multiple functional stoichiometries, which exhibit distinct sensitivities to agonists and different rates of desensitization, providing a potential basis for highly selective pharmacological intervention [2, 4]. The α3β2 nAChR is considered a promising therapeutic target for cognitive enhancement and the treatment of neurodevelopmental and neurodegenerative disorders, including Alzheimer's disease, attention deficit hyperactivity disorder (ADHD), and autism spectrum disorder [3, 4]. Genetic studies have also linked variations in the α3 subunit to nicotine dependence and alcohol abuse [9]. Pharmacologically, the receptor is activated by agonists like nicotine and varenicline and is potently inhibited by specific toxins such as alpha-conotoxin MII [5]. A major challenge in targeting this receptor is achieving selectivity over the α3β4 subtype found in autonomic ganglia to avoid systemic side effects such as cardiovascular and gastrointestinal distress [2].

Other names

Neuronal nicotinic acetylcholine receptor alpha3beta2CHRNA3-CHRNB2 receptorα3β2 nicotinic receptorAlpha3beta2 nAChR

The alpha-3 beta-2 nicotinic acetylcholine receptor is a pentameric ligand-gated ion channel that mediates fast excitatory neurotransmission. Upon binding of agonists such as acetylcholine or nicotine, the receptor undergoes a conformational change that opens a central pore, allowing the influx of cations (primarily Na+ and Ca2+) and the efflux of K+. This ion flow results in membrane depolarization and can trigger downstream signaling pathways or modulate the release of other neurotransmitters, particularly in the hippocampus and autonomic ganglia [1, 2, 8].